(Q50951092)

English

Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in vitro and in vivo.

scientific article published on 9 June 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22691433

Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in vitro and in vivo. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22691433

1 reference

based on heuristic

inferred from title

author name string

Anusara Daenthanasanmak

1

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22691433

Gustavo Salguero

2

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22691433

Sylvia Borchers

3

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22691433

Constanca Figueiredo

4

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22691433

Roland Jacobs

5

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22691433

Bala Sai Sundarasetty

6

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22691433

Andreas Schneider

7

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22691433

Axel Schambach

8

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22691433

Britta Eiz-Vesper

9

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22691433

Rainer Blasczyk

10

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22691433

Eva M Weissinger

11

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22691433

Arnold Ganser

12

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22691433

Renata Stripecke

13

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22691433

language of work or name

0 references

publication date

9 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22691433

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22691433

30

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22691433

34

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22691433

5118-5131

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22691433

Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Relationship of reconstituted adaptive and innate cytomegalovirus (CMV)-specific immune responses with CMV viremia in hematopoietic stem cell transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Dendritic cell vaccination in allogeneic stem cell recipients: induction of human cytomegalovirus (HCMV)-specific cytotoxic T lymphocyte responses even in patients receiving a transplant from an HCMV-seronegative donor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Lentiviral vector-mediated autonomous differentiation of mouse bone marrow cells into immunologically potent dendritic cell vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Lentiviral vectors for induction of self-differentiation and conditional ablation of dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Identity, potency, in vivo viability, and scaling up production of lentiviral vector-induced dendritic cells for melanoma immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Dendritic cell recovery after autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Preconditioning therapy with lentiviral vector-programmed dendritic cells accelerates the homeostatic expansion of antigen-reactive human T cells in NOD.Rag1-/-.IL-2rγc-/- mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Unintegrated lentivirus DNA persistence and accessibility to expression in nondividing cells: analysis with class I integrase mutants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Integrase-defective lentiviral vectors: progress and applications.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Effective gene therapy with nonintegrating lentiviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Successful Immunization with a Single Injection of Non-integrating Lentiviral Vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Protective Antiviral Immunity Conferred by a Nonintegrative Lentiviral Vector-Based Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Transduction of human antigen-presenting cells with integrase-defective lentiviral vector enables functional expansion of primed antigen-specific CD8(+) T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Development of a HIV-1 lipopeptide antigen pulsed therapeutic dendritic cell vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Development of 2A peptide-based strategies in the design of multicistronic vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Lentiviral vector-mediated genetic programming of mouse and human dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Making dendritic cells from the inside out: lentiviral vector-mediated gene delivery of granulocyte-macrophage colony-stimulating factor and interleukin 4 into CD14+ monocytes generates dendritic cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

The natural alliance between type I interferon and dendritic cells and its role in linking innate and adaptive immunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

IFN- Skews Monocytes into CD56+-Expressing Dendritic Cells with Potent Functional Activities In Vitro and In Vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Large-scale manufacture and characterization of a lentiviral vector produced for clinical ex vivo gene therapy application

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Efficient large volume lentiviral vector production using flow electroporation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

HIV-1 in peripheral blood monocytes: an underrated viral source

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

The role of unintegrated DNA in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Transcription of preintegrated HIV-1 cDNA modulates cell surface expression of major histocompatibility complex class I via Nef.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Stable transduction of primary human monocytes by simian lentiviral vector PBj.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Interferon-alpha and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

IFN-α-conditioned dendritic cells are highly efficient in inducing cross-priming CD8+ T cells against exogenous viral antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

IFN-alpha in the generation of dendritic cells for cancer immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

DC-SIGN (CD209) Expression Is IL-4 Dependent and Is Negatively Regulated by IFN, TGF- , and Anti-Inflammatory Agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

DC-SIGN mediated sphingomyelinase-activation and ceramide generation is essential for enhancement of viral uptake in dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Monocyte derived dendritic cells generated by IFN-alpha acquire mature dendritic and natural killer cell properties as shown by gene expression analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.05.063

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.05.063

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22691433

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/22691433

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50951092&oldid=1790387739"